A Pharmacokinetic Study Comparing EG1206A and Perjeta (Pertzumab) in Healthy Male Volunteers
Clinical trial NCT05471648 · COMPLETED
Trial details
- NCT number
- NCT05471648
- Sponsor
- EirGenix, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-16
- Primary completion
- 2023-01-24
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.